Synlogic Inc Net Assets
Synlogic Inc net assets. Based on the latest financial reports, Synlogic Inc (SYBX) has net assets worth $11.86 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($15.45 Million) and total liabilities ($3.58 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset momentum of Synlogic Inc to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $11.86 Million |
| % of Total Assets | 76.8% |
| Annual Growth Rate | N/A |
| 5-Year Change | -91.94% |
| 10-Year Change | -80.34% |
| Growth Volatility | 39.17 |
Net Assets of Synlogic Inc (2013–2025)
Net assets of Synlogic Inc from 2013 to 2025. This chart illustrates how Synlogic Inc's net assets have evolved over time, based on quarterly financial data. See how leveraged is Synlogic Inc's balance sheet to measure how much of total assets are equity-financed.
Annual Net Assets for Synlogic Inc (2013–2025)
The table below shows the annual net assets of Synlogic Inc from 2013 to 2025. For live market cap and overall valuation, see SYBX market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $11.86 Million | -6.96% |
| 2024-12-31 | $12.75 Million | -70.11% |
| 2023-12-31 | $42.66 Million | -48.37% |
| 2022-12-31 | $82.61 Million | -43.90% |
| 2021-12-31 | $147.27 Million | +27.91% |
| 2020-12-31 | $115.14 Million | -26.62% |
| 2019-12-31 | $156.91 Million | +26.44% |
| 2018-12-31 | $124.10 Million | +45.93% |
| 2017-12-31 | $85.04 Million | +40.90% |
| 2016-12-31 | $60.35 Million | -29.01% |
| 2015-12-31 | $85.02 Million | +277.30% |
| 2014-12-31 | $-47.95 Million | -60.30% |
| 2013-12-31 | $-29.91 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Synlogic Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 41185200000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Synlogic Inc Net Assets Breakdown (December 2025)
Synlogic Inc net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $12.00K | 0.10% |
| Other Components | $454.51 Million | 3831.30% |
| Total Equity | $11.86 Million | 100.00% |
Synlogic Inc Competitors by Market Cap
The table below lists competitors of Synlogic Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Pudjiadi Prestige Tbk
JK:PUDP
|
$7.49 Million |
|
Enlitic Inc
AU:ENL
|
$7.50 Million |
|
Lantern Pharma Inc
NASDAQ:LTRN
|
$7.50 Million |
|
Hemostemix Inc
V:HEM
|
$7.50 Million |
|
TEN Holdings, Inc. Common Stock
NASDAQ:XHLD
|
$7.49 Million |
|
Advanced Medical Solutions Group plc
LSE:AMS
|
$7.49 Million |
|
Auction Technology Group PLC
LSE:ATG
|
$7.48 Million |
|
Lombard et Medot SA
PA:MLCAC
|
$7.48 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Synlogic Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 12,751,000 to 11,863,000, a change of -888,000 (-7.0%).
- Net loss of 1,005,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.00 Million | -8.47% |
| Other Changes | $117.00K | +0.99% |
| Total Change | $- | -6.96% |
Book Value vs Market Value Analysis
This analysis compares Synlogic Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.21x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $-26.41 | $1.17 | x |
| 2014-12-31 | $-42.33 | $1.17 | x |
| 2015-12-31 | $118.78 | $1.17 | x |
| 2016-12-31 | $20.28 | $1.17 | x |
| 2017-12-31 | $189.69 | $1.17 | x |
| 2018-12-31 | $77.94 | $1.17 | x |
| 2019-12-31 | $77.72 | $1.17 | x |
| 2020-12-31 | $48.19 | $1.17 | x |
| 2021-12-31 | $39.92 | $1.17 | x |
| 2022-12-31 | $17.28 | $1.17 | x |
| 2023-12-31 | $6.56 | $1.17 | x |
| 2024-12-31 | $1.05 | $1.17 | x |
| 2025-12-31 | $0.96 | $1.17 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Synlogic Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -8.47%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.30x
- Recent ROE (-8.47%) is above the historical average (-52.70%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.44 Million |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-11.04 Million |
| 2015 | -29.39% | 0.00% | 0.00x | 1.07x | $-33.48 Million |
| 2016 | -43.52% | -5916.22% | 0.01x | 1.06x | $-32.30 Million |
| 2017 | -47.48% | -1652.09% | 0.02x | 1.17x | $-48.88 Million |
| 2018 | -39.03% | -1922.02% | 0.02x | 1.13x | $-60.84 Million |
| 2019 | -31.02% | -2188.44% | 0.01x | 1.20x | $-64.36 Million |
| 2020 | -49.10% | -10373.76% | 0.00x | 1.25x | $-68.05 Million |
| 2021 | -39.46% | -3313.45% | 0.01x | 1.19x | $-72.84 Million |
| 2022 | -80.07% | -5605.68% | 0.01x | 1.34x | $-74.41 Million |
| 2023 | -134.29% | -1699.26% | 0.04x | 1.77x | $-61.55 Million |
| 2024 | -183.19% | -291987.50% | 0.00x | 1.55x | $-24.63 Million |
| 2025 | -8.47% | 0.00% | 0.00x | 1.30x | $-2.19 Million |
Industry Comparison
This section compares Synlogic Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $211,904,180
- Average return on equity (ROE) among peers: 1119.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Synlogic Inc (SYBX) | $11.86 Million | 0.00% | 0.30x | $7.49 Million |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-54.64 Million | 0.00% | 0.00x | $27.43 Million |
| Abcellera Biologics Inc (ABCL) | $1.15 Billion | -12.70% | 0.29x | $3.53 Billion |
| Abeona Therapeutics Inc (ABEO) | $178.43 Million | -42.75% | 0.25x | $241.32 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $181.82 Million | -56.28% | 0.31x | $15.62 Million |
| Abpro Holdings, Inc. (ABP) | $-14.95 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $-41.16 Million | 0.00% | 0.00x | $1.41 Billion |
| Arbutus Biopharma Corp (ABUS) | $155.53K | 11625.26% | 37.80x | $804.31 Million |
| ABVC Biopharma Inc (ABVC) | $35.27K | -72.00% | 1.50x | $26.65 Million |
| Abivax SA American Depositary Shares (ABVX) | $17.90 Million | -209.78% | 2.98x | $7.77 Billion |
| ACADIA Pharmaceuticals Inc (ACAD) | $699.13 Million | -33.65% | 0.12x | $3.70 Billion |
About Synlogic Inc
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.